Longitudinal migration patterns from an open illicit drug scene among people who use illicit drugs in Vancouver, Canada.


Journal

Journal of substance abuse treatment
ISSN: 1873-6483
Titre abrégé: J Subst Abuse Treat
Pays: United States
ID NLM: 8500909

Informations de publication

Date de publication:
12 2019
Historique:
received: 14 01 2019
revised: 23 09 2019
accepted: 27 09 2019
entrez: 24 11 2019
pubmed: 24 11 2019
medline: 1 9 2020
Statut: ppublish

Résumé

The objective of this study was to identify migration patterns from an open illicit drug scene (the Downtown Eastside [DTES] neighborhood) and describe factors associated with these migration patterns. Data were derived from three cohorts of people who use illicit drugs in Vancouver, Canada. Defined using latent class growth analysis, we identified four distinct migration trajectory groups: 1) consistently living in the DTES (47.8%); 2) early migration out, with a median time of migrating out of DTES of 5.3 months (21.5%); 3) late migration out, with a median time of migrating out of DTES of 38.0 months (20.1%); and 4) frequent revisit back-and-forth to DTES (10.6%). In a multivariable model, compared to the "consistently living in the DTES" group, factors associated with the "frequent revisit" group included being enrolled in non-pharmacological addiction treatment and having an HCV-positive serostatus. Factors associated with the "early migration out" group included being enrolled in detoxification or in other non-pharmacological addiction treatment, later calendar year, being on income assistance, living in a single room occupancy hotel, and having an HCV-positive serostatus. These findings point to the need for appropriate distribution of services in order to meet the needs of this population.

Identifiants

pubmed: 31757260
pii: S0740-5472(19)30013-3
doi: 10.1016/j.jsat.2019.09.006
pmc: PMC6892597
mid: NIHMS1543949
pii:
doi:

Substances chimiques

Illicit Drugs 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17-23

Subventions

Organisme : NIDA NIH HHS
ID : U01 DA021525
Pays : United States
Organisme : NIDA NIH HHS
ID : U01 DA038886
Pays : United States
Organisme : CIHR
ID : MSH-141971
Pays : Canada

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

Health Policy. 2014 Nov;118(2):201-14
pubmed: 25176511
JAMA. 1998 Aug 12;280(6):547-9
pubmed: 9707146
Subst Use Misuse. 2014 Jun;49(7):891-901
pubmed: 24611820
Harm Reduct J. 2009 Jul 31;6:22
pubmed: 19646255
Health Place. 2008 Sep;14(3):536-43
pubmed: 18410717
AIDS. 1997 Jul;11(8):F59-65
pubmed: 9223727
AIDS Behav. 2010 Aug;14(4):854-61
pubmed: 18427970
Br J Addict. 1992 Feb;87(2):251-8
pubmed: 1313321
Lancet. 2015 Nov 28;386(10009):2130
pubmed: 26638953
Urban Aff Rev Thousand Oaks Calif. 2008;43(6):846-874
pubmed: 19655037
Int J Offender Ther Comp Criminol. 2011 Jun;55(4):567-86
pubmed: 20463206
Int J Infect Dis. 2017 Feb;55:31-37
pubmed: 28027990
Harm Reduct J. 2006 May 24;3:18
pubmed: 16723029
BMJ. 2009 Apr 30;338:b1649
pubmed: 19406887
Soc Sci Med. 2007 Aug;65(3):572-85
pubmed: 17475383
BMJ Open. 2016 Jan 06;6(1):e009043
pubmed: 26739726
J Clin Pharm Ther. 2007 Oct;32(5):497-504
pubmed: 17875117
Int J Drug Policy. 2015 Jan;26(1):43-50
pubmed: 25304048
Addiction. 2012 Jul;107(7):1318-27
pubmed: 22248184
Drug Alcohol Depend. 2007 Nov 2;91(1):50-6
pubmed: 17561355
Int J Drug Policy. 2009 May;20(3):193-201
pubmed: 19147339
AIDS. 2001 Jul 27;15(11):1329-41
pubmed: 11504954
Am J Epidemiol. 2011 Apr 1;173(7):829-36
pubmed: 21320867
BMC Public Health. 2017 May 2;17(1):376
pubmed: 28464942
Soc Sci Med. 2005 Aug;61(3):673-84
pubmed: 15899325
Int J Drug Policy. 2014 May;25(3):608-15
pubmed: 24332972
Drug Alcohol Depend. 2014 Nov 1;144:141-7
pubmed: 25248472
BMC Public Health. 2014 Aug 16;14:853
pubmed: 25128331
Int J Drug Policy. 2008 Apr;19(2):140-7
pubmed: 18207725
Health Place. 2012 Mar;18(2):152-62
pubmed: 21955638
Alcohol Clin Exp Res. 2000 Jun;24(6):882-91
pubmed: 10888079
Health Place. 2007 Jun;13(2):432-9
pubmed: 16798055
Can J Public Health. 2005 Nov-Dec;96(6):459-61
pubmed: 16350874
J Subst Abuse Treat. 2009 Sep;37(2):120-6
pubmed: 19150202
J Urban Health. 2007 Sep;84(5):653-66
pubmed: 17657607
Am J Drug Alcohol Abuse. 2006;32(1):87-110
pubmed: 16450645

Auteurs

Lianping Ti (L)

British Columbia Centre on Substance Use, 400-1045 Howe Street, Vancouver, BC V6Z 2A9, Canada; Department of Medicine, University of British Columbia, St. Paul's Hospital, 608-1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada.

Huiru Dong (H)

British Columbia Centre on Substance Use, 400-1045 Howe Street, Vancouver, BC V6Z 2A9, Canada.

Andrew Day (A)

Vancouver Coastal Health Authority, 520 West 6th Avenue, Vancouver, BC V5Z 1A1, Canada.

Rachael McKendry (R)

Vancouver Coastal Health Authority, 520 West 6th Avenue, Vancouver, BC V5Z 1A1, Canada.

Kora DeBeck (K)

British Columbia Centre on Substance Use, 400-1045 Howe Street, Vancouver, BC V6Z 2A9, Canada; School of Public Policy, Simon Fraser University, 515 West Hastings Street, Vancouver, BC V6B 5K3, Canada.

Brittany Bingham (B)

Vancouver Coastal Health Authority, 520 West 6th Avenue, Vancouver, BC V5Z 1A1, Canada.

M-J Milloy (MJ)

British Columbia Centre on Substance Use, 400-1045 Howe Street, Vancouver, BC V6Z 2A9, Canada; Department of Medicine, University of British Columbia, St. Paul's Hospital, 608-1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada.

Rolando Barrios (R)

Vancouver Coastal Health Authority, 520 West 6th Avenue, Vancouver, BC V5Z 1A1, Canada; British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 608-1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada.

Kanna Hayashi (K)

British Columbia Centre on Substance Use, 400-1045 Howe Street, Vancouver, BC V6Z 2A9, Canada; Faculty of Health Sciences, Simon Fraser University, Blusson Hall, 8888 University Drive, Burnaby, BC V5A 1S6, Canada. Electronic address: bccsu-kh@bccsu.ubc.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH